hit counter
Amgen Inc. (AMGN) Stock News Sentiment & Price - Sentifly
AMGN - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Amgen Inc. (AMGN)

USA
Biotechnology
NASDAQ
AMGN Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
AMGN Latest news
The Motley Fool
Positive
Here Are the Highlights From Amgen's Q3 Results
2021-11-11 07:01

The big biotech reported only modest sales growth.

PRNewsWire
Neutral
Amgen To Present At The 2021 Annual Cowen IO Summit
2021-11-10 16:00

THOUSAND OAKS, Calif., Nov. 10, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2021 annual Cowen IO Summit at 2:15 p.m.

InvestorPlace
Positive
3 Nasdaq Stocks to Buy and Hold for Years
2021-11-10 12:25

There's no question that stocks in the Nasdaq composite index have seen massive gains over the last year and a half. Even after taking a back seat to cyclicals late last year, the index continues to hit new heights.

Seeking Alpha
Positive
3 Safe High-Yield Blue-Chips That Can Triple The Market's Returns In The Next 5 Years
2021-11-09 20:14

The S&P has posted 63 record closes this year, and is now 29% overvalued. Stocks could potentially keep melting up into Q1 of next year. But just because the market is being stupid doesn't mean you have to be.

Seeking Alpha
Neutral
Upcoming Ex-Dividend Dates: November 10-22, 2021
2021-11-09 12:47

We provide a summary of upcoming ex-dividend dates in a quick reference table. The table includes relevant data and key statistics as well as the next payout and pay date.

Seeking Alpha
Positive
The Best 9%-25%+ Undervalued Companies Today
2021-11-09 12:34

Looking at the market today, it's clear that while some segments and companies suffer from overvaluation, this is far from a universal state. There are massively undervalued investment opportunities, where you essentially get paid to wait for the company to appreciate.

PRNewsWire
Neutral
First And Only Randomized, Double-blind, Head-to-head Study Comparing Aimovig® (erenumab-aooe), An Anti-CGRP Pathway Therapy, To Topiramate Published In Cephalalgia
2021-11-08 16:09

THOUSAND OAKS, Calif., Nov. 8, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data from the HER-MES study, the first and only head-to-head study of Aimovig® (erenumab-aooe), a calcitonin gene-related peptide (CGRP) inhibitor, against topiramate for adult patients with episodic and chronic migraine.

Seeking Alpha
Positive
The Near-Perfect Portfolio For The Good Times And Bad
2021-11-06 09:00

No portfolio or strategy can be perfect. But can there be a strategy that can work well in a bull market, a bear market, or a stagnant market, generate a decent income, and conserve capital, all at the same time? We also want our strategy to avoid roller-coaster rides of index investing, have low volatility and limited drawdowns in case of deep corrections.

Seeking Alpha
Neutral
Amgen's Product Portfolio Shuffles To Sustain Growth
2021-11-06 04:49

Amgen's Product Portfolio Shuffles To Sustain Growth

Zacks Investment Research
Neutral
How Are Biotech ETFs Reacting to These Q3 Earnings Releases?
2021-11-06 00:50

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

Loading more news...